(EMN) Eastman Chemical - Ratings and Ratios
Additives, Solvents, Copolyesters, Cellulosics, Plasticizers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.42% |
| Yield on Cost 5y | 4.03% |
| Yield CAGR 5y | 5.12% |
| Payout Consistency | 96.7% |
| Payout Ratio | 50.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 37.4% |
| Value at Risk 5%th | 55.4% |
| Relative Tail Risk | -9.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.14 |
| Alpha | -57.34 |
| CAGR/Max DD | -0.15 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.352 |
| Beta | 1.197 |
| Beta Downside | 1.193 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.40% |
| Mean DD | 14.04% |
| Median DD | 9.05% |
Description: EMN Eastman Chemical November 04, 2025
Eastman Chemical Company (NYSE: EMN) is a diversified specialty materials producer operating in the United States, China, and other international markets. Its portfolio is organized into four primary segments: Additives & Functional Products, Advanced Materials, Chemical Intermediates, and Fibers, each targeting a broad set of end-markets ranging from transportation and construction to personal care and electronics.
The Additives & Functional Products segment supplies amine-derived building blocks, surfactant intermediates, soil-fumigant precursors, organic-acid solutions, specialty coalescents, solvents, paint additives, specialty polymers, and heat-transfer/aviation fluids. This segment benefits from ongoing demand for higher-performance coatings and low-VOC formulations, especially in automotive and consumer-goods applications.
Advanced Materials focuses on copolyesters, cellulosic biopolymers, polyvinyl butyral (PVB) sheets, and polyester films used in transportation, durable goods, electronics, construction, medical/pharma, and consumables. The Chemical Intermediates segment delivers olefin and acetyl derivatives, ethylene, commodity solvents, and both non-phthalate and phthalate plasticizers, serving industrial chemicals, construction, health-wellness, and food/feed markets. The Fibers segment produces cellulose-acetate tow, triacetin, acetate flake, acetic acid, and acetic anhydride for filtration media, acetate yarns, staple fibers, wet-laid nonwovens, engineered papers, and specialty fibers for transportation, aerospace, and agricultural uses.
Key financial metrics from FY 2023 show revenue of approximately $11.5 billion, adjusted EBITDA margin near 12 %, free cash flow of $1.2 billion, and a capital-expenditure program of roughly $900 million aimed at expanding sustainable polymer capacity. The segment’s growth is closely tied to macro-level drivers such as the global chemicals market’s 3 % CAGR, tightening regulations on phthalate plastics, and accelerating demand for bio-based and high-performance materials.
For a deeper, data-driven view of Eastman’s valuation dynamics and how its segment trends compare to peers, you may find it worthwhile to explore the detailed analysis available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (699.0m TTM) > 0 and > 6% of Revenue (6% = 541.4m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -1.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.07% (prev 14.42%; Δ 3.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 1.01b > Net Income 699.0m (YES >=105%, WARN >=100%) |
| Net Debt (4.59b) to EBITDA (1.45b) ratio: 3.15 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (115.4m) change vs 12m ago -2.04% (target <= -2.0% for YES) |
| Gross Margin 22.83% (prev 23.39%; Δ -0.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.08% (prev 62.03%; Δ -1.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.04 (EBITDA TTM 1.45b / Interest Expense TTM 219.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.47
| (A) 0.11 = (Total Current Assets 3.79b - Total Current Liabilities 2.16b) / Total Assets 14.98b |
| (B) 0.67 = Retained Earnings (Balance) 10.10b / Total Assets 14.98b |
| (C) 0.06 = EBIT TTM 884.0m / Avg Total Assets 15.02b |
| (D) 1.10 = Book Value of Equity 10.10b / Total Liabilities 9.14b |
| Total Rating: 4.47 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.13
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.58% |
| 3. FCF Margin 4.42% |
| 4. Debt/Equity 0.87 |
| 5. Debt/Ebitda 3.15 |
| 6. ROIC - WACC (= -3.24)% |
| 7. RoE 12.02% |
| 8. Rev. Trend -78.31% |
| 9. EPS Trend -20.40% |
What is the price of EMN shares?
Over the past week, the price has changed by +6.63%, over one month by -3.97%, over three months by -9.19% and over the past year by -39.23%.
Is EMN a buy, sell or hold?
- Strong Buy: 10
- Buy: 3
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EMN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 72.8 | 18.8% |
| Analysts Target Price | 72.8 | 18.8% |
| ValueRay Target Price | 58.9 | -3.9% |
EMN Fundamental Data Overview November 20, 2025
P/E Trailing = 9.601
P/E Forward = 9.2251
P/S = 0.7318
P/B = 1.1363
P/EG = 3.4178
Beta = 1.253
Revenue TTM = 9.02b USD
EBIT TTM = 884.0m USD
EBITDA TTM = 1.45b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 290.0m USD (from shortLongTermDebt, last quarter)
Debt = 5.02b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.59b USD (from netDebt column, last quarter)
Enterprise Value = 11.13b USD (6.60b + Debt 5.02b - CCE 489.0m)
Interest Coverage Ratio = 4.04 (Ebit TTM 884.0m / Interest Expense TTM 219.0m)
FCF Yield = 3.58% (FCF TTM 399.0m / Enterprise Value 11.13b)
FCF Margin = 4.42% (FCF TTM 399.0m / Revenue TTM 9.02b)
Net Margin = 7.75% (Net Income TTM 699.0m / Revenue TTM 9.02b)
Gross Margin = 22.83% ((Revenue TTM 9.02b - Cost of Revenue TTM 6.96b) / Revenue TTM)
Gross Margin QoQ = 19.66% (prev 22.13%)
Tobins Q-Ratio = 0.74 (Enterprise Value 11.13b / Total Assets 14.98b)
Interest Expense / Debt = 1.08% (Interest Expense 54.0m / Debt 5.02b)
Taxrate = 64.93% (87.0m / 134.0m)
NOPAT = 310.1m (EBIT 884.0m * (1 - 64.93%))
Current Ratio = 1.76 (Total Current Assets 3.79b / Total Current Liabilities 2.16b)
Debt / Equity = 0.87 (Debt 5.02b / totalStockholderEquity, last quarter 5.77b)
Debt / EBITDA = 3.15 (Net Debt 4.59b / EBITDA 1.45b)
Debt / FCF = 11.49 (Net Debt 4.59b / FCF TTM 399.0m)
Total Stockholder Equity = 5.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.67% (Net Income 699.0m / Total Assets 14.98b)
RoE = 12.02% (Net Income TTM 699.0m / Total Stockholder Equity 5.81b)
RoCE = 8.34% (EBIT 884.0m / Capital Employed (Equity 5.81b + L.T.Debt 4.79b))
RoIC = 2.85% (NOPAT 310.1m / Invested Capital 10.87b)
WACC = 6.09% (E(6.60b)/V(11.62b) * Re(10.43%) + D(5.02b)/V(11.62b) * Rd(1.08%) * (1-Tc(0.65)))
Discount Rate = 10.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.40%
[DCF Debug] Terminal Value 71.90% ; FCFE base≈477.4m ; Y1≈530.1m ; Y5≈693.3m
Fair Price DCF = 71.36 (DCF Value 8.14b / Shares Outstanding 114.1m; 5y FCF grow 12.71% → 3.0% )
EPS Correlation: -20.40 | EPS CAGR: -11.60% | SUE: -0.22 | # QB: 0
Revenue Correlation: -78.31 | Revenue CAGR: -5.21% | SUE: -1.83 | # QB: 0
Additional Sources for EMN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle